Article
Alpha-1 Antitrypsin Augmentation Therapy
7 Mar 2013
Abstract excerpt
The therapy of alpha-1 antitrypsin deficiency (AATD) is an example of a medical triumph over a common hereditary disease. Based on the understanding of the pathogens of the disease as a deficiency in liver production of alpha-1 antitrypsin (AAT) resulting from inherited genetic variation in both parental AAT genes, the knowledge that A1AT functions primarily to inhibit neutrophil elastase (NE), and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
